Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $13.0254 is 47.51% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 13.33||$ 22.32|
|Low:||$ 12.92||$ 8.83|
Company Description (as filed with the SEC)
Calyxt was incorporated in the State of Delaware in 2010 and is a majority-owned subsidiary of Cellectis, a leading gene-editing company focused on the development of immuno-oncology therapeutics. We are a healthy food ingredient company. We leverage proprietary intellectual property, our technical expertise, and an end-to-end supply chain toward our mission of "Making the Food You Love a Healthier ChoiceTM". Using our proprietary technologies and expertise, including TALEN gene-editing technology exclusively licensed to us in the field of agriculture, we develop food crops with targeted traits quickly and more cost effectively than traditional methods. Our technologies enable precise cuts to DNA in a single plant cell using the plant's natural repair machinery. This allows us to make our desired genome edit and regenerate the single cell into a full plant that includes this gene edit. ... More ...
Nasdaq Official Price
Jun. 19, 2019
Jun. 18, 2019